NUNZIA PHARMACEUTICAL COMPANY Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
NUNZIA PHARMACEUTICAL COMPANY reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of -$14.63 thousand for the 9-month period ending 2021-09-30, per its 10-Q/A filed 2022-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2022-03-29
- NUNZIA PHARMACEUTICAL COMPANY increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2021-09-30 was -$14.76K, a 844.45% decline year-over-year.
- NUNZIA PHARMACEUTICAL COMPANY increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2021-06-30 was $1.51K, a 4.63% increase year-over-year.
- NUNZIA PHARMACEUTICAL COMPANY increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2021-03-31 was -$1.39K.
- NUNZIA PHARMACEUTICAL COMPANY increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2020-09-30 was $1.98K.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month |
|---|---|---|---|
| 2021-09-30 | -$14.76K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2022-03-29 | -$13.24K derived: sum of 2 quarters · filed 2022-03-29 | -$14.63K 10-Q/A · filed 2022-03-29 |
| 2021-06-30 | $1.51K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2022-03-29 | $126.00 10-Q/A · filed 2022-03-29 | |
| 2021-03-31 | -$1.39K 10-Q/A · filed 2022-03-29 | ||
| 2020-09-30 | $1.98K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2022-03-29 | $3.43K derived: sum of 2 quarters · filed 2022-03-29 | $3.43K 10-Q/A · filed 2022-03-29 |
| 2020-06-30 | $1.45K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2022-03-29 | $1.45K 10-Q/A · filed 2022-03-29 | |
| 2020-03-31 | $0.00 10-Q/A · filed 2022-03-29 |